News

For the planned series of Phase II multi-centered, controlled clinical trials to be performed in the US, Innocoll has appointed Premier Research Group to co-ordinate up to five

The first product to be developed will target the hepatitis B hyperimmune. Kedrion has in-licensed ProMetic’s technologies for the manufacturing of hyperimmune products in Europe. Royalties, licensing and

Glenmark commenced shipping immediately upon final approval from the FDA for an abbreviated new drug application (ANDA) for Nabumetone tablets in 500mg and 750mg strengths and Hydroxyzine hydrochloride

Omron Healthcare has developed two blood pressure monitors for the series, a manual upper-arm and automatic upper-arm model. Both are charged by exposure to sunlight through the solar

Under the terms of the collaboration agreement, Suven will receive research funding and as well as potential discovery and development milestone payments in the range of $19 million

The transaction is expected to close within 60 days, subject to the satisfaction of customary closing conditions, including Hart-Scott-Rodino clearance. The $117.8 million purchase price consists of $48

Watson’s levonorgestrel and ethinyl estradiol product is a generic version of Wyeth’s Lybrel tablets which is indicated for the prevention of pregnancy. Wyeth has filed suit against Watson

Ibudone provides the highest hydrocodone or ibuprofen dosage available, 10mg of hydrocodone/200mg of ibuprofen in each tablet. Peak plasma levels are achieved in less than two hours. Ibudone

Granisol is the AA-rated equivalent of Roche’s Kytril oral solution. Granisol oral solution is available through all the national drug wholesalers as well as multiple other distribution channels